我国现阶段有效实施《药品召回管理办法》的思考与建议  

Perspectives on Current Effective Enforcement of Drug Recall Administration in China

作　　者：张欣涛[1] 卢来春[2] 平其能[1] 

机构地区：[1]中国药科大学,南京市210009 [2]第三军医大学第二附属医院药学部,重庆市400037

出　　处：《中国药房》2008年第29期2241-2243,共3页China Pharmacy

摘　　要：目的:强化《药品召回管理办法》的实施力度。方法:通过对《药品召回管理办法》的学习、解读以及对国内外药品召回现状的分析,探讨确保《药品召回管理办法》有效实施的措施。结果与结论:在《药品召回管理办法》实施起步阶段,应当从药品生产企业、消费群体、相关配套制度等几方面入手,采取积极措施,确保该规章得到有效实施。OBJECTIVE： To strengthen the implementation of Drug Recall Administration （DRA）. METHODS： Based on the study of ＂DRA＂ and the analysis of the current drug recall status both in China and abroad, effective measures for the enforcement of the regulation was presented. RESULTS ＆ CONCLUSIONS： In the initial enforcement stage of ＂DRA＂, some relative effective measures should be taken from the aspects of drug manufacturing enterprises, consumers and the related supporting regulations to ensure the effective enforcement of the regulation.

关 键 词：药品召回管理办法 缺陷药品 药品不良反应 

分 类 号：R951[医药卫生—药学]